PATH $14.42 on 22 Jan 2026: UiPath Inc. (NYSE) AI demand supports upside into earnings
PATH stock trades at $14.42 intraday on 22 Jan 2026 as UiPath Inc. (PATH) shows steady AI-driven revenue expansion but light volume ahead of its March earnings date. We see a mixed short-term technical picture with volume 2,646,171 and a PE 33.80 that prices growth expectations. This update connects UiPath’s fundamentals, trading signals, analyst consensus and Meyka AI forecasts to the current NYSE price and the AI software sector context in the United States.
PATH stock: current price, liquidity and valuation
UiPath Inc. (PATH) is trading at $14.42 on the NYSE with volume 2,646,171 versus an average volume of 24,298,167, showing lower intraday liquidity. The shares opened at $14.49 and are within a day range $14.41–$14.78. Valuation shows EPS $0.42 and PE 33.80, and market cap stands near $7.59B USD. Short-term traders should note the 50-day average price $15.65 and 200-day average $13.34 as reference levels.
PATH stock: recent financial growth and margins
UiPath reported strong 2024 growth metrics with revenue growth of 23.57% year-over-year and net income growth near 72.63%, indicating margin recovery in a high-margin software model. Gross margin is 83.16% and net profit margin is 14.79%, while the current ratio is 2.54, reflecting solid liquidity. These fundamentals underpin the PATH stock narrative that AI and RPA adoption are lifting revenue per share to $2.88 TTM.
Meyka AI rates PATH with a score out of 100 and analyst consensus
Meyka AI rates PATH with a score out of 100: 75.98 (B+) — Suggestion: BUY. This grade factors in S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus. The upgrade/downgrade table shows 1 Buy, 10 Hold, consensus midpoint 3.00, which matches our neutral-to-positive view on execution and AI demand.
PATH stock technicals and short-term trading setup
Technicals are neutral to slightly bearish intraday: RSI 48.95, MACD 0.22 (signal 0.26), and ADX 18.02 indicating no strong trend. Volatility measures show ATR 0.96 and Bollinger bands at $15.35–$17.91. The setup suggests range trading between the 50-day mean $15.65 and support at the 200-day mean $13.34 while momentum waits on macro and AI-sector cues.
PATH stock risks, opportunities and realistic price targets
Key risks include a high price-to-sales near 4.85, extended receivables at 116.59 days, and below-average intraday liquidity. Opportunities center on AI automation demand in banking and healthcare and improving free cash flow yield 4.13%. Meyka-aligned targets: monthly $18.90, quarterly $17.92, yearly $16.65, giving potential upside if AI adoption accelerates. See recent market commentary on PATH at MarketBeat and Nasdaq.
Final Thoughts
Key takeaways: PATH stock trades at $14.42 on 22 Jan 2026 with healthy margins and improving cash flow, but intraday liquidity is below its 50-day average. Meyka AI’s forecast model projects a near-term monthly target of $18.90, a quarterly target of $17.92, and a yearly target of $16.65. The monthly target implies an upside of 31.07% versus today’s price, while the yearly target implies 15.46% upside from $14.42 USD. Our Meyka grade B+ (75.98) reflects growth and sector strength balanced against valuation and receivables risk. Forecasts are model-based projections and not guarantees. Investors should watch the March 11, 2026 earnings date, relative sector movement in Technology, and any guidance changes that could alter PATH stock’s risk-reward profile. Meyka AI provides this as AI-powered market analysis for context, not investment advice.
FAQs
What is PATH stock trading at today and where is it listed?
PATH stock is trading at $14.42 intraday on 22 Jan 2026 and is listed on the NYSE in the United States. Volume today is 2,646,171 with a 50-day average price of $15.65.
What are the key valuation metrics for UiPath (PATH)?
UiPath shows EPS $0.42, PE 33.80, price-to-sales near 4.85, and free cash flow yield roughly 4.13%. These metrics reflect growth expectations priced into PATH stock.
What price targets does Meyka AI give for PATH stock?
Meyka AI’s forecast model projects monthly $18.90, quarterly $17.92, and yearly $16.65. These are model-based projections and not guarantees.
What are the main risks to PATH stock in the near term?
Near-term risks include stretched receivables (116.59 days), a relatively high valuation, and thin intraday liquidity versus average volume. Earnings guidance will be a catalyst.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
